Clinically Verified Osteoarthritis “Wondergel” Launches in Singapore

Singapore (PRWEB United kingdom) 29 October 2013

FLEXISEQ, the award winning new drug-free therapy for osteoarthritis is now offered in Singapore. Clinically verified* in Europe to be as effective at discomfort relief as the prescription drug celecoxib, but with an exceptional security profile, Flexiseq has been hailed in Europe as a “Wondergel”*. Flexiseq has currently won The Innovation Award 2013 from the Federal Association of German Pharmacists for its breakthrough Nano Engineering.

&#13

Flexiseq is a specially formulated gel, which does not contain any pharmaceutically energetic elements. FLEXISEQ includes Sequessome Technology, a new sophisticated engineering designed in and manufactured in Germany.

&#13

Sequessome Technology consists of nanostructures that are able to cross by means of the skin barrier, following FLEXISEQ gel’s topical application, and target the joint ache location. As the vesicles attain the within of the joint, they act as a bodily bio-lubricant to lubricate the joint, strengthening osteoarthritis patients physical function and substantially reducing soreness.

&#13

Adjunct Assistant Professor Sathappan, Senior Consultant, Department of Orthopaedic Surgical treatment, Tan Tock Seng Hospital, has employed topical gel as means of treating osteoarthritis. He mentioned, Early to reasonable osteoarthritis can be effectively managed with topical gel. They can facilitate optimal end result with physiotherapy and let in practical rehabilitation. Sufferers are usually averse to taking drugs and osteoarthritis also has an effect on elderly patients with a number of health care co-morbidities who are presently on a number of oral medications. Thus a topical gel as a therapy will be significantly much better obtained by patients.

&#13

Investigation conducted by Singhealth shows that osteoarthritis impacts an estimated forty% of the Singapore grownup population. Until finally now, the offered treatments were drugs, injections or surgical procedure which all have troubles for the individuals and medical doctors. As the Flexiseq gel does not include any drug, it might be utilised as a long term treatment alternative on its personal and as an extension to other drugs prescribed to greatest decrease discomfort related with osteoarthritis. Several of the old medicines can only be used for short intervals of time.

&#13

Commented by a GP in Singapore, Dr Paul Ho, Flexiseq is effective and relieves pain for osteoarthritis individuals. That is why patients return for more Flexiseq.

&#13

In a trial conducted in Europe*, which concerned more than 1,300 individuals, it was discovered that those who utilized Flexiseq twice a day benefited from pain reduction equivalent to the prescription drug celecoxib without having the health risks associated with the previous therapies.

&#13

Dr Matthias Rother said: This is an crucial examine which additional confirms the safety and efficacy of FLEXISEQ for remedy of the persistent soreness and stiffness that troubles so several patients with OA. The effect size noticed for Flexiseq is comparable to the impact sizes noticed in a comparative examine employing the identical design and style which demonstrated that FLEXISEQ has equivalent efficacy to the broadly utilized oral NSAID, celecoxib. That examine was published in Rheumatology earlier this 12 months (Conaghan et 2013). These two studies are between a number of which persistently show the advantages of this drug-free of charge gel.

&#13

A spokeswoman for Arthritis Research United kingdom also claimed that, This new remedy could supply people at increased chance of these troubles a risk-free and effective different type of ache relief.

&#13

Flexiseq is now obtainable in GP clinics and soon offered to all hospital pharmacies and retail pharmacies.

&#13

About Adjunct Assistant Professor Sathappan

&#13

Adjunct Assistant Professor Sathappan is a Advisor in the Division of Orthopaedics in Tan Tock Seng Hospital with a special curiosity in grownup reconstructive surgical procedure, sports surgical procedure &amp management of complex pelvic and acetabular trauma. Getting graduated from University of Bristol, United Kingdom in 1995, Dr. Sathappan then proceed to obtained his FRCSEd in 1999. Thereafter, he completed his superior surgical instruction in Orthopaedics in 2003 and obtained his FRCSEd (Ortho &amp Trauma) and subsequently finished a 1-12 months specialty fellowship in Grownup Reconstructive surgical procedure in the Hospital for Joint Conditions in New York, USA.

&#13

About Dr. Matthias Rother

&#13

Dr. Matthias Rother has more than 25 many years experience in research and advancement in academia, big pharma, biotech and contract analysis. He studied medication and founded a Phase I unit at the University Hospital for Neurology in Jena ahead of joining the Max Planck Institute for Neurology Research in Cologne. In 1992, he started out his profession in the pharmaceutical business as a clinical task manager at the headquarters of the Hoechst AG. His last position with the successor company Aventis was Director New Items Neuroscience at the Drug Growth Centre in Bridgewater, New Jersey with worldwide responsibilities. After his return to Germany in 2000, he became 1 of two executive directors at a spin off firm from the Technical University of Munich with a transdermal drug delivery engineering (Notion AG). He had direct duty for task management, clinical and preclinical growth, toxicology, and analytics/top quality management and top quality assurance. Matthias sophisticated 6 items into phase I, 4 goods in phase II, two goods into phase III and one product was submitted to the EMEA making use of the centralized method and was authorized in Switzerland. This is primarily based on intensive regulatory contacts to the FDA, EMEA and local EU companies (scientific suggestions, pre-IND, pre-NDA meetings). Matthias has founded two support organizations.

&#13

About Pro Bono

&#13

PBB has ambitious development targets that will enable it to assistance a unique humanitarian mission. In 2012 it supported elderly pilgrims on the Hajj to Mecca, alleviating the joint soreness brought on by extended intervals of walking and kneeling. Pro Bono Bio is an modern pharmaceutical and nano healthcare device business launched in 2011. Professional Bono Bio launched Flexiseq in Europe in the first half of 2012 and ideas to launch two even more new goods for the treatment method of inflammatory skin disorders later on this year. These new products, ROSSOSEQ

Comments are closed.